Implementing Fragmentomics Into Real World Screening IntervenTions to Evaluate Clinical Utility Among Individuals With Elevated Risk for Lung Cancer

NCT06145750 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DIAGNOSTIC_TEST: Ability to order FirstLook™
OTHER: Continuing Medical Education for Lung Cancer

Sponsor

Delfi Diagnostics Inc.